- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05030259
The Research About the ACS After Femoropopliteal Arterial Injuries
August 25, 2021 updated by: Hebei Medical University Third Hospital
ACS After Femoropopliteal Arterial Injuries
Crural Compartment syndrome is a well-known sequela after femoropopliteal arterial injuries in the lower extremity, particularly when there has been a long period of ischemia,need for ligation of a major vein, or when there is severe associated soft tissue.There is conteoversy in the treatment.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hebei
-
Shijiazhuang, Hebei, China, 050000
- Recruiting
- the Third Hospital of Hebei Medical Univesity
-
Contact:
- Sun Changsheng
- Phone Number: 15176139310
- Email: 15176139310@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The patients with femoropopliteal arterial injuries in our hospital who will be treated with vascular repair.
Description
Inclusion Criteria:
- patients with femoropopliteal arterial injuries
- patients older than 18 years
Exclusion Criteria:
- Patients who did not survive to discharge
- Patients with primary amputation
- patients younger than 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
patients with fasciotomy
|
To perform fasciotomy
|
|
patients without fasciotomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the rate of amputation
Time Frame: up to 6 months
|
up to 6 months
|
|
fasciotomy performed or not
Time Frame: up to 2 weeks
|
up to 2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the rate of primary skin closure
Time Frame: up to 1 months
|
up to 1 months
|
|
|
hospital lengths of stay
Time Frame: up to 6 months
|
up to 6 months
|
|
|
injury mechanism of patients
Time Frame: up to 1 week
|
up to 1 week
|
|
|
the costs of hospitalization
Time Frame: up to 2 months
|
up to 2 months
|
|
|
tourniquet used or not
Time Frame: up to 1 week
|
up to 1 week
|
|
|
the time of using tourniquet
Time Frame: up to 1 week
|
up to 1 week
|
|
|
the time to surgical intervention
Time Frame: up to 1 month
|
up to 1 month
|
|
|
extremity Abbreviated Injury Scale of patients
Time Frame: up to 1 week
|
minimum is 1, maximum is 6, higher scores mean a worse outcome
|
up to 1 week
|
|
Injury Severity Score of patients
Time Frame: up to 1 week
|
minimum is 0, maximum is 75, higher scores mean a worse outcome
|
up to 1 week
|
|
concomitant injury of patients
Time Frame: up to 1 week
|
up to 1 week
|
|
|
time of skin closure
Time Frame: up to 1 month
|
up to 1 month
|
|
|
admission hemoglobin of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
admission pH of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
admission lactate of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
postoperative lactate of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
admission International Normalized Ratio of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
postoperative International Normalized Ratio of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
admission CK of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
postoperative CK of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
admission LDH of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
postoperative LDH of patients
Time Frame: up to 1 month
|
up to 1 month
|
|
|
Number of Participants with Lower Extremity Arteriosclerosis Obliterans
Time Frame: up to 1 week
|
up to 1 week
|
|
|
vascular repair technique of patients
Time Frame: up to 1 week
|
up to 1 week
|
|
|
Number of Participants with sepsis
Time Frame: up to 1 month
|
up to 1 month
|
|
|
Ischemia time of patients
Time Frame: up to 1 week
|
up to 1 week
|
|
|
Postoperative knee function of patients
Time Frame: up to 6 month
|
up to 6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hou Zhiyong, Doctor, Hebei medical university third hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2021
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
December 31, 2030
Study Registration Dates
First Submitted
August 3, 2021
First Submitted That Met QC Criteria
August 25, 2021
First Posted (Actual)
September 1, 2021
Study Record Updates
Last Update Posted (Actual)
September 1, 2021
Last Update Submitted That Met QC Criteria
August 25, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HZY005ACS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
acute compartment syndrome
IPD Sharing Time Frame
2 years after the experiment was conducted
IPD Sharing Access Criteria
all authors focusing on ACS research
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Compartment Syndrome
-
University of AberdeenNHS Grampian; Softcell Medical LtdNot yet recruitingAcute Compartment SyndromeUnited Kingdom
-
J&M ShulerCompletedAcute Compartment SyndromeUnited States
-
McGill University Health Centre/Research Institute...United States Department of Defense; Vanderbilt University Medical Center; Hennepin...RecruitingAcute Compartment SyndromeUnited States
-
Major Extremity Trauma Research ConsortiumCompleted
-
J&M ShulerUnited States Department of Defense; Nonin MedicalUnknownAcute Compartment SyndromeUnited States
-
J&M ShulerUnited States Department of Defense; Somanetics CorporationCompletedAcute Compartment SyndromeGermany
-
MY01 Inc.McGill University Health Centre/Research Institute of the McGill University... and other collaboratorsCompletedAcute Compartment SyndromeCanada
-
J&M ShulerNonin Medical, IncCompletedAcute Compartment SyndromeUnited States
-
Hebei Medical University Third HospitalRecruiting
-
Nanjing PLA General HospitalCompletedTrauma Abdomen | Acute Compartment Syndrome | Damage Control
Clinical Trials on fasciotomy
-
Bispebjerg HospitalRecruitingCompartment Syndrome Nontraumatic Lower LegDenmark
-
Hebei Medical University Third HospitalRecruiting
-
Jeppe Lange, MDCompletedDupuytrens ContractureDenmark
-
Hvidovre University HospitalNot yet recruitingPlantar Fascitis | Surgical Treatment | Randomized Study | Non-operative Treatment
-
University of Missouri-ColumbiaWound Care Technologies, Inc.TerminatedWounds and Injuries | Compartment SyndromeUnited States
-
Oslo University HospitalUnknownDupuytrens ContractureNorway
-
ArthroCare CorporationCompleted
-
Sunnybrook Health Sciences CentreUnknown
-
University of CalgaryUnknownDupuytren Contracture | Dupuytren's Disease of FingerCanada
-
Regionshospitalet SilkeborgRecruitingNeoplasms | Neoplasms, Connective and Soft Tissue | Neoplasms by Histologic Type | Joint Diseases | Musculoskeletal Diseases | Connective Tissue Diseases | Neoplasms, Connective Tissue | Fibroma | Contracture | Dupuytren Contracture | Dupuytren's Disease | Neoplasm, Fibrous TissueDenmark